RecruitingNot Applicable

Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

United States44 participantsStarted 2026-06

Plain-language summary

Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence. Exclusion Criteria: * neurogenic bladder, BMI \>40, or peripheral neuropathy.

What they're measuring

Radiation Exposure

Timeframe: At time of procedure

Trial details

NCT IDNCT04527445

SponsorLoma Linda University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-06

Contact for this trial

Forrest Jellison, MD

909 558-2830 fjellison@llu.edu

View on ClinicalTrials.gov More Radiation Exposure trials